相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Many faces of the same myeloid neoplasm: a case of leukaemia cutis with mixed histiocytic and Langerhans cell differentiation
Vignesh Shanmugam et al.
JOURNAL OF CLINICAL PATHOLOGY (2019)
Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia
Nolwenn Lucas et al.
LEUKEMIA (2019)
The emergence of a JAK2 V617F-mutated clone in myelodysplastic syndrome is associated with disease progression and features of myelofibrosis
Boris Zhong et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
Peter Valent et al.
HAEMATOLOGICA (2019)
Genomic landscape of neutrophilic leukemias of ambiguous diagnosis
Haijiao Zhang et al.
BLOOD (2019)
How Morphologic Features Are Shaped By Underlying Somatic Genotype in MDS
Yasunobu Nagata et al.
BLOOD (2019)
Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes
Yasunobu Nagata et al.
NATURE COMMUNICATIONS (2019)
Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features
Valeria Visconte et al.
CANCERS (2019)
Myelodysplastic syndrome progression to acute myeloid leukemia at the stem cell level
Jiahao Chen et al.
NATURE MEDICINE (2019)
RUNX1 Mutations Can Lead to Aberrant Expression of CD79a and PAX5 in Acute Myelogenous Leukemias: A Potential Diagnostic Pitfall
Thomas Menter et al.
PATHOBIOLOGY (2019)
IKZF1 deletion and co-occurrence with other aberrations in a child with chronic myeloid leukemia progressing to acute lymphoblastic leukemia
Claudete Esteves Klumb et al.
PEDIATRIC BLOOD & CANCER (2019)
Does SF3B1/TET2 Double Mutation Portend Better or Worse Prognosis Than Isolated SF3B1 or TET2 Mutation?
Jinming Song et al.
CANCER GENOMICS & PROTEOMICS (2019)
Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years
Varinder Kaur et al.
HEMATOLOGY (2018)
Efficacy and safety of midostaurin in patients with advanced systemic mastocytosis: 10-year median follow-up of a phase II trial
D. J. DeAngelo et al.
LEUKEMIA (2018)
Profile of fibrosis-related gene transcripts and megakaryocytic changes in the bone marrow of myelodysplastic syndromes with fibrosis
Kais Hussein et al.
ANNALS OF HEMATOLOGY (2018)
Gene mutations and clonal architecture in myelodysplastic syndromes and changes upon progression to acute myeloid leukaemia and under treatment
Juliane M. Stosch et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
The mutational landscape of 18 investigated genes clearly separates four subtypes of myelodysplastic/myeloproliferative neoplasms
Manja Meggendorfer et al.
HAEMATOLOGICA (2018)
A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone
Mrinal M. Patnaik et al.
LEUKEMIA (2018)
Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations
Christophe Willekens et al.
LEUKEMIA (2018)
The mutational landscape of 18 investigated genes clearly separates four subtypes of myelodysplastic/myeloproliferative neoplasms
Manja Meggendorfer et al.
HAEMATOLOGICA (2018)
Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016
Alexandar Tzankov et al.
ANNALS OF HEMATOLOGY (2018)
Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable
Prithviraj Bose et al.
BLOOD (2018)
Routes of Clonal Evolution into Complex Karyotypes in Myelodysplastic Syndrome Patients with 5q Deletion
Simone Feurstein et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
BCR-ABL1 Positive B-ALL Can Undergo T-cell Lineage Shift to Become CD19 Negative T-ALL
Jolien De Bie et al.
HEMASPHERE (2018)
Clinical characteristics of Philadelphia positive T-cell lymphoid leukemias-(De novo and blast phase CML)
Preetesh Jain et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Dynamics of clonal evolution in myelodysplastic syndromes
Hideki Makishima et al.
NATURE GENETICS (2017)
Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: Expanding the spectrum of skin lesions in chronic myelomonocytic leukemia
Sanam Loghavi et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2017)
Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia
Julia T. Geyer et al.
MODERN PATHOLOGY (2017)
Individual risk assessment in MDS in the era of genomic medicine
Catherine Cargo et al.
SEMINARS IN HEMATOLOGY (2017)
Sharing of a PTPN11 mutation by myelodysplastic bone marrow and a mature plasmacytoid dendritic cell proliferation provides evidence for their common myelomonocytic origin
Andrea Bodmer et al.
VIRCHOWS ARCHIV (2017)
Transcriptional and Microenvironmental Regulation of Lineage Ambiguity in Leukemia
Tianyuan Hu et al.
FRONTIERS IN ONCOLOGY (2017)
The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia
Adam S. Sperling et al.
NATURE REVIEWS CANCER (2017)
Gene expression and risk of leukemic transformation in myelodysplasia
Yusuke Shiozawa et al.
BLOOD (2017)
Hematopoietic stem cell involvement in BCR-ABL1-positive ALL as a potential mechanism of resistance to blinatumomab therapy
Inga Nagel et al.
BLOOD (2017)
A Consensus Review on Malignancy-Associated Hemophagocytic Lymphohistiocytosis in Adults
Naval Daver et al.
CANCER (2017)
Plasmacytoid dendritic cell proliferations and neoplasms involving the bone marrow
Alexandar Tzankov et al.
ANNALS OF HEMATOLOGY (2017)
Pure Erythroid Leukemia and Erythroblastic Sarcoma Evolving From Chronic Myeloid Neoplasms
Hongmei Li et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing
Mrinal M. Patnaik et al.
AMERICAN JOURNAL OF HEMATOLOGY (2016)
Histiocytic sarcoma as a secondary malignancy: pathobiology, diagnosis, and treatment
Junaid Ansari et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2016)
Myeloid neoplasms with isolated isochromosome 17q demonstrate a high frequency of mutations in SETBP1, SRSF2, ASXL1 and NRAS
Rashmi Kanagal-Shamanna et al.
ONCOTARGET (2016)
Acute Myeloid Leukemia and Other Types of Disease Progression in Myeloproliferative Neoplasms
Magdalena Czader et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)
ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia
Michelle A. Elliott et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma
Z. Li et al.
LEUKEMIA (2015)
Detectable FLT3-ITD or RAS mutation at the time of transformation from MDS to AML predicts for very poor outcomes
Talha Badar et al.
LEUKEMIA RESEARCH (2015)
The genomic landscape of juvenile myelomonocytic leukemia
Elliot Stieglitz et al.
NATURE GENETICS (2015)
Atypical chronic myeloid leukemia with concomitant CSF3R T618I and SETBP1 mutations unresponsive to the JAK inhibitor ruxolitinib
Emanuele Ammatuna et al.
ANNALS OF HEMATOLOGY (2015)
SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution
Chien-Chin Lin et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms
Sa A. Wang et al.
BLOOD (2014)
Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems
Bin Fu et al.
MODERN PATHOLOGY (2014)
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients
M. M. Patnaik et al.
LEUKEMIA (2014)
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome
T-C Chen et al.
BLOOD CANCER JOURNAL (2014)
Early precursor T-lymphoblastic leukaemia/lymphoma arising from paediatric chronic myeloid leukaemia - unusual lymph node blast crisis
Mingying Zhang et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
Development of monocytosis in patients with primary myelofibrosis indicates an accelerated phase of the disease
Leonardo Boiocchi et al.
MODERN PATHOLOGY (2013)
Clinicopathologic analysis of acute myeloid leukemia arising from chronic myelomonocytic leukemia
Elizabeth L. Courville et al.
MODERN PATHOLOGY (2013)
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
M. J. Walter et al.
LEUKEMIA (2013)
Specific Skin Lesions in Chronic Myelomonocytic Leukemia A Spectrum of Myelomonocytic and Dendritic Cell Proliferations. A Study of 42 Cases
Franck Vitte et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2012)
Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg et al.
BLOOD (2012)
SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients
T. L. Lasho et al.
LEUKEMIA (2012)
Cutaneous manifestations in CMML: Indication of disease acceleration or transformation to AML and review of the literature
Rahel A. Mathew et al.
LEUKEMIA RESEARCH (2012)
Cytopenia, Dysplasia, and Monocytosis: A Precursor To Chronic Myelomonocytic Leukemia or a Distinct Subgroup? Case Reports and Review of Literature
Zeba N. Singh et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2011)
A deep-sequencing study of chronic myeloid leukemia patients in blast crisis (BC-CML) detects mutations in 76.9% of cases
V. Grossmann et al.
LEUKEMIA (2011)
Clinical Effect of Point Mutations in Myelodysplastic Syndromes
Rafael Bejar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Hemophagocytosis associated with leukemia: a striking association with juvenile myelomonocytic leukemia
Sule Unal et al.
ANNALS OF HEMATOLOGY (2010)
Histiocytic sarcoma and underlying chronic myelomonocytic leukemia: a proposal for the developmental classification of histiocytic sarcoma
Minako Mori et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Acute myeloid leukemia initially presenting as hemophagocytic lymphohistiocytosis-A case report and review of the literature
Li-xia Wang et al.
LEUKEMIA RESEARCH (2010)
Myeloid Sarcoma Extramedullary Manifestation of Myeloid Disorders
Cristina Campidelli et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2009)
Immunosuppressive treatment in patient with pure red cell aplasia associated with chronic myelomonocytic leukemia: harm or benefit?
Saloni Tanna et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Sudden extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia - A nonrandom event associated with imatinib?
Annette S. Kim et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemias
Dan Jones et al.
BLOOD (2008)
BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros
Charles G. Mullighan et al.
NATURE (2008)
A der(1;15)(q10;q10) is a rare nonrandom whole-arm translocation in patients with acute lymphoblastic leukemia
Tae Sung Park et al.
CANCER GENETICS AND CYTOGENETICS (2007)
Myeloid sarcoma: clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients
S. A. Pileri et al.
LEUKEMIA (2007)
Chronic myelomonocytic leukemia: the role of bone marrow biopsy immunohistology
Attilio Orazi et al.
MODERN PATHOLOGY (2006)
Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de Novo disease
Sa A. Wang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome
C-Y Chen et al.
LEUKEMIA (2006)
The JAK2 V617F tyrosine kinase mutation in myelodysplastic syndromes (MDS) developing myelofibrosis indicates the myeloproliferative nature in a subset of MDS patients
K Ohyashiki et al.
LEUKEMIA (2005)
Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: A basis for clinical decision making
L Malcovati et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia
LY Shih et al.
LEUKEMIA (2004)
PAX5 expression in acute leukemias: Higher B-Lineage specificity than CD79a and selective association with t(8;21)-acute myelogenous leukemia
E Tiacci et al.
CANCER RESEARCH (2004)
分享论文
